Jun 27, 2025 | Defective Drugs, Defective Product, Depo-Provera, Product Liability
Depo-Provera, the brand name for the injectable contraceptive medroxyprogesterone acetate (DMPA), has been widely used for decades by women seeking a convenient, long-lasting form of birth control. While many rely on it for effective pregnancy prevention, serious...
Apr 24, 2025 | Defective Drugs, Defective Medical Device, Defective Product, Depo-Provera, Product Liability
For decades, Depo-Provera has been marketed as a convenient and long-lasting form of birth control. The injectable contraceptive, also known as depot medroxyprogesterone acetate (DMPA), has been widely prescribed to millions of women in the United States and around...
Feb 26, 2025 | Defective Drugs, Depo-Provera, Multidistrict Litigation, Product Liability
For decades, Depo-Provera has been a widely used injectable contraceptive. It often receives praise for its convenience and long-term effectiveness. However, recent lawsuits are emerging linking Depo-Provera to serious health risks, including the development of...
Dec 4, 2024 | Defective Drugs, Defective Product, Depo-Provera, Product Liability
Depo-Provera, a widely used birth control injection, has been hailed as a convenient option for women seeking long-term contraception. However, the medication has come under scrutiny due to reports of severe side effects and complications, including an increased risk...
Nov 19, 2024 | Defective Drugs, Defective Product, Depo-Provera, Product Liability
Depo-Provera, an injectable contraceptive containing the synthetic hormone medroxyprogesterone acetate (MPA), has been widely used for decades as an effective birth control method. While it is valued for its convenience and long-term efficacy, concerns have emerged...
